Using a traditional clinical-site recruitment approach is no longer the only option in observational research. With the increased adoption of electronic informed consent methods by the FDA, it is now feasible to conduct real world evidence (RWE) studies using a virtual model that eliminates entirely the need for clinical sites. We present the elements required to conduct prospective virtual RWE studies, including online patient recruitment, e-consent, patient-centric call center support, physician oversight, online questionnaires, and local lab testing. We also cover the elements needed to conduct retrospective virtual RWE studies using electronic data that can replace the need for an expensive prospective study. Both of these models show great promise in lowering the cost and improving the efficacy of current, site-based RWE studies.
John D. McDermott Jr, MBA
VP, Covance Market Access
TBC
Stephen O. Crawford, PhD, MHS
Director, Global HEOR, Covance Market Access
TBC
Peter M. Wahl, ScD, MLA, MS
Pharmacoepidemiologist, Covance Market Access
TBC
- Understand the implications of electronic informed consent by the FDA
- Understand the elements of conducting a prospective virtual RWE study
- Understand the elements of conducting a retrospective virtual RWE study
- Heads of HEOR
- Heads of Medical Affairs
- Heads of Real World Evidence
- Heads of Evidence Generation
- Heads of Outcomes Research
- Heads of Data